Initiation, treatment response evaluation, and safety monitoring of angiotensin receptor/neprilysin inhibitors (Sacubitril/Valsartan) in the management of heart failure in India: An expert group recommendations

Angiotensin receptor/neprilysin inhibitors (ARNI) have become a pillar of heart failure (HF) management. Clinicians gain practical insight into the use of sacubitril/valsartan in patients with HF with reduced ejection fraction (EF) from a comprehensive overview based on clinical experience with ARNI...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Uday M Jadhav, V K Chopra, S Ray, A Oomman
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2023-01-01
Edice:	Journal of Indian College of Cardiology
Témata:	angiotensin receptor/neprilysin inhibitor heart failure sacubitril valsartan subject matter expert
On-line přístup:	http://www.joicc.org/article.asp?issn=1561-8811;year=2023;volume=13;issue=4;spage=141;epage=146;aulast=Jadhav
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!